Genes Dysregulated in Autism as Potential Biomarkers and Therapeutic Targets
University of California System: University of California, Los Angeles - UCLA
posted on 05/02/2012
Brief description unavailable
- Identifies a cohort of gene expression changes in the disease-relevant tissue (ASD brain).
- Can be used as genetic biomarkers for the accurate and early diagnosis of ASD in young children.
- Describes the dysregulated molecular pathways that may include candidates for preventive approaches or treatment therapeutics for ASD patients.
- Some of the gene changes are also seen in peripheral blood lymphocytes, indicating that they may serve as biomarkers for ASD diagnosis.
File Number: 22469
Disease: Central Nervous System
|Copyright:||©2012-2014, The Regents of the University of California|
This innovation currently is not available for online licensing. Please contact UCLA Office of Intellectual Property & Industry Sponsored Research at University of California System: University of California, Los Angeles - UCLA for more information.request more info
Find more innovations